Bihag, Joseph T.
HRN: 22 55 00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/03/2023
02/09/2023
IVT
4.5 G
Q6
Community Acquired Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes